| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Imodium Advanced (Loperamide HCI and Simethicone) Caplet McNeil Consumer Healthcare NDA 21-140 11/29/00 12/12/01 12/12/01 12/12/01 Imodium A-D Caplets McNeil Consumer Healthcare NDA 19860/S-018 Loperamide Hydrochloride & Simethicone Chewable Tablets, 2 mg/125 mg, OTC L. Perrigo Company ANDA 76-029 8/30/02 Loperamide Hydrochloride Tablets USP, 2 mg LNK International ANDA 76-497 6/10/03 Loperamide Hydrochloride Tablets USP, 2 mg L. Perrigo Company ANDA 75-232 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL GENEVA 017694 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG IMODIUM MCNEIL CONS SPECLT 072741 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL MYLAN 073122 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL TEVA 073192 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL TEVA |
|
© 2009 Betterchem.com
|